Sporadic late onset nemaline myopathy with monoclonal gammopathy of undetermined significance: two cases with long term stability
-
Published:2020-09-16
Issue:3
Volume:30
Page:
-
ISSN:2037-7460
-
Container-title:European Journal of Translational Myology
-
language:
-
Short-container-title:Eur J Transl Myol
Author:
Truffert André,Iancu Ferfoglia Ruxandra,Lobrinus Johannes Alexander,Samii Kaveh,Kohler André
Abstract
Monoclonal gammopathy of undetermined significance (MGUS) associated to sporadic late onset nemaline myopathy (SLONM) is a rare and severely disabling condition of quickly progressive limb girdle acquired myopathy. It is believed by some authors to be due to myotoxicity of light chain deposits. Two female patients were diagnosed with MGUS associated SLONM. In the first case, diagnosis was delayed by 6 years thus giving time for a severe generalized myopathy and cardiomyopathy to develop. A single anti-myeloma chemotherapy with lenalidomide markedly improved and stabilized the patient’s condition despite respiratory and cardiac insufficiency. In our second patient the condition was identified one year after onset of the first symptom and markedly improved after autologous bone marrow transplantation and lenalidomide. Clinicians should be aware of monoclonal gammopathy associated sporadic late onset nemaline myopathy as this acquired muscle disorder, although extremely rare, may be reversed by adequate management.
Publisher
PAGEPress Publications
Subject
Cell Biology,Neurology (clinical),Molecular Biology,Orthopedics and Sports Medicine
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献